1. Home
  2. RWAY vs PGEN Comparison

RWAY vs PGEN Comparison

Compare RWAY & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RWAY
  • PGEN
  • Stock Information
  • Founded
  • RWAY 2015
  • PGEN 1998
  • Country
  • RWAY United States
  • PGEN United States
  • Employees
  • RWAY N/A
  • PGEN N/A
  • Industry
  • RWAY
  • PGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • RWAY
  • PGEN Health Care
  • Exchange
  • RWAY Nasdaq
  • PGEN Nasdaq
  • Market Cap
  • RWAY 395.5M
  • PGEN 404.4M
  • IPO Year
  • RWAY 2021
  • PGEN N/A
  • Fundamental
  • Price
  • RWAY $9.93
  • PGEN $1.32
  • Analyst Decision
  • RWAY Buy
  • PGEN Strong Buy
  • Analyst Count
  • RWAY 6
  • PGEN 4
  • Target Price
  • RWAY $10.75
  • PGEN $7.33
  • AVG Volume (30 Days)
  • RWAY 344.4K
  • PGEN 1.8M
  • Earning Date
  • RWAY 05-12-2025
  • PGEN 05-14-2025
  • Dividend Yield
  • RWAY 12.09%
  • PGEN N/A
  • EPS Growth
  • RWAY 51.80
  • PGEN N/A
  • EPS
  • RWAY 1.67
  • PGEN N/A
  • Revenue
  • RWAY $140,021,000.00
  • PGEN $4,201,000.00
  • Revenue This Year
  • RWAY N/A
  • PGEN $189.12
  • Revenue Next Year
  • RWAY N/A
  • PGEN $1,093.07
  • P/E Ratio
  • RWAY $5.96
  • PGEN N/A
  • Revenue Growth
  • RWAY N/A
  • PGEN N/A
  • 52 Week Low
  • RWAY $8.35
  • PGEN $0.65
  • 52 Week High
  • RWAY $12.17
  • PGEN $2.17
  • Technical
  • Relative Strength Index (RSI)
  • RWAY 57.59
  • PGEN 44.03
  • Support Level
  • RWAY $9.65
  • PGEN $1.35
  • Resistance Level
  • RWAY $9.95
  • PGEN $1.53
  • Average True Range (ATR)
  • RWAY 0.23
  • PGEN 0.12
  • MACD
  • RWAY 0.04
  • PGEN 0.00
  • Stochastic Oscillator
  • RWAY 65.26
  • PGEN 22.22

About RWAY Runway Growth Finance Corp.

Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and Canada, with the majority of its portfolio invested in the United States.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: